Gas chromatography-mass spectrometry analysis of human mesenchymal stem cell metabolism during proliferation and osteogenic differentiation under different oxygen tensions

Journal of Biotechnology

Volumn 169, Issue 1, 2014, Pages 95-102

  Muñoz, Nathalie ^a   Kim, Junho ^b   Liu, Yijun ^b   Logan, Timothy M ^a   Ma, Teng ^a,b  

^a FLORIDA STATE UNIVERSITY   (United States)

^b FAMU FSU COLLEGE OF ENGINEERING   (United States)

Author keywords

Human mesenchymal stem cells; Hypoxia; Metabolism; Osteogenic differentiation; Proliferation

Indexed keywords

BONE TISSUE ENGINEERING; GAS CHROMATOGRAPHY-MASS SPECTROMETRIES (GC-MS); GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMAN MESENCHYMAL STEM CELLS; HYPOXIA; OSTEOGENIC DIFFERENTIATION; PROLIFERATION; TRICARBOXYLIC ACID CYCLE;

BONE; GAS CHROMATOGRAPHY; ISOTOPES; METABOLITES; OXYGEN; PATHOLOGY; STEM CELLS; TISSUE ENGINEERING;

METABOLISM;

ASPARTIC ACID; CARBON 13; GLUCOSE; ISOTOPE; MALIC ACID; OXYGEN;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL METABOLISM; CELL PROLIFERATION; CITRIC ACID CYCLE; GLYCOLYSIS; HUMAN; HUMAN CELL; MASS FRAGMENTOGRAPHY; MESENCHYMAL STEM CELL; METABOLITE; OSTEOBLAST; OSTEOGENIC DIFFERENTIATION; OXYGEN TENSION; PHENOTYPE; PRIORITY JOURNAL;

HUMAN MESENCHYMAL STEM CELLS; HYPOXIA; METABOLISM; OSTEOGENIC DIFFERENTIATION; PROLIFERATION;

CELL DIFFERENTIATION; CELL PROLIFERATION; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MESENCHYMAL STROMAL CELLS; METABOLOME; OSTEOGENESIS; OXYGEN;

EID: 84889671092     PISSN: 01681656     EISSN: 18734863     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2013.11.010     Document Type: Article

References (45)

1. Brauman J.I. Least squares analysis and simplification of multi-isotope mass spectra. Anal. Chem. 1966, 38:607-610.
2. Clarke B. Normal bone anatomy and physiology. Clin. J. Am. Soc. Nephrol. 2008, 3:S131-S139.
3. Des Rosiers C., Lloyd S., Comte B., Chatham J.C. A critical perspective of the use of 13C-isotopomer analysis by GCMS and NMR as applied to cardiac metabolism. Metab. Eng. 2004, 6:44-58.
4. Dimmer K., Friedrich B., Lang F., Deitmer J., Bröer S. The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. Biochem. J. 2000, 350:219-227.
5. Dos Santos F., Andrade P.Z., Boura J.S., Abecasis M.M., Da Silva C.L., Cabral J.M.S. Ex vivo expansion of human mesenchymal stem cells: a more effective cell proliferation kinetics and metabolism under hypoxia. J. Cell. Physiol. 2009, 223:27-35.
6. Estrada J.C., Albo C., Bengura A., Dopazo A., Lopez-Romero P., Carrera-Quintanar L., Roche E., Clemente E.P., Enriquez J.A., Bernad A., Samper E. Culture of human mesenchymal stem cells at low oxygen tension improves growth and genetic stability by activating glycolysis. Cell Death Differ. 2012, 19:743-755.
7. Fehrer C., Brunauer R., Laschober G., Unterluggauer H., Reitinger S., Kloss F., Gülly C., Gaßner R., Lepperdinger G. Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell 2007, 6:745-757.
8. Fraley C., Raferty A., Scrucca L. mclust: Normal Mixture Modeling for Model-Based Clustering, Classification, and Density Estimation. R Package version 4.0 2012.
9. Giannoni P., Scaglione S., Daga A., Ilengo C., Cilli M., Quarto R. Short-time survival and engraftment of bone marrow stromal cells in an ectopic model of bone regeneration. Tissue Eng. Part A 2010, 16:489-499.
10. Grayson W.L., Ma T., Bunnell B. Human mesenchymal stem cells tissue development in 3D PET matrices. Biotechnol. Prog. 2004, 20:905-912.
11. Grayson W.L., Zhao F., Izadpanah R., Bunnell B., Ma T. Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs. J. Cell. Physiol. 2006, 207:331-339.
12. Grayson W.L., Zhao F., Bunnell B., Ma T. Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem. Biophys. Res. Commun. 2007, 358:948-953.
13. Halestrap A.P. The monocarboxylate transporter family - structure and functional characterization. IUBMB Life 2012, 64:1-9.
14. Halestrap A.P., Wilson M.C. The monocarboxylate transporter family - role and regulation. IUBMB Life 2012, 64:109-119.
15. Jäger M., Degistirici Ö., Knipper A., Fischer J., Sager M., Krauspe R. Bone healing and migration of cord blood - derived stem cells into a critical size femoral defect after xenotransplantation. J. Bone Miner. Res. 2007, 22:1224-1233.
16. Jennings M.E., Matthews D.E. Determination of complex isotopomer patterns in isotopically labeled compounds by mass spectrometry. Anal. Chem. 2005, 77:6435-6444.
17. Kim J.W., Tchernyshyov I., Semenza G.L., Dang C.V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 2006, 3:177-185.
18. Kubinyi H. Calculation of isotope distributions in mass spectrometry. A trivial solution for a non-trivial problem. Anal. Chim. Acta 1991, 247:107-119.
19. Lavrentieva A., Majore I., Kasper C., Hass R. Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells. Cell Commun. Signal. 2010, 8:18.
20. Lee W.-N., Byerley L.O., Bergner E.A., Edmond J. Mass isotopomer analysis: theoretical and practical considerations. Biol. Mass Spectrom. 1991, 20:451-458.
21. Lu C.-W., Lin S.-C., Chen K.-F., Lai Y.-Y., Tsai S.-J. Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance. J. Biol. Chem. 2008, 283:28106-28114.
22. Ma T., Grayson W.L., Fröhlich M., Vunjak-Novakovic G. Hypoxia and stem cell-based engineering of mesenchymal tissues. Biotechnol. Prog. 2009, 25:32-42.
23. Mawhinney T.P., Robinett R.S., Atalay A., Madson M.A. Analysis of amino acids as their tert-butyldimethylsilyl derivatives by gas-liquid chromatography and mass spectrometry. J. Chromatogr. 1986, 358:231-242.
24. Mawhinney T.P., Robinett R.S., Atalay A., Madson M.A. Gas-liquid chromatography and mass spectral analysis of mono-, di-, and tricarboxylates as their tert-butyldimenthylsilyl derivatives. J. Chromatogr. 1986, 361:117-130.
25. Metallo C.M., Walther J.L., Stephanopoulos G. Evaluation of 13C isotopic tracers for metabolic flux analysis in mammalian cells. J. Biotechnol. 2009, 144:167-174.
26. Mullen K.M., Van Stokkum I.H.M. nnls: The Lawson-Hanson algorithm for non-negative least squares (nnls) 2010.
27. Mylotte L.A., Duffy A.M., Murphy M., O'Brien T., Samali A., Barry F., Szegezdi E. Metabolic flexibility permits mesenchymal stem cell survival in ischemic environment. Stem Cells 2008, 26:1325-1336.
28. Nicolaije C., Koedam M., Van Leeuwen J.P.T.M. Decreased oxygen tension lowers reactive oxygen species and apoptosis and inhibits osteoblast matrix mineralization through changes in early osteoblast differentiation. J. Cell. Physiol. 2012, 227:1309-1318.
29. Nielsen T.T., Stottrup N.B., Lofgren B., Botker H.E. Metabolic fingerprint of ischaemic cardioprotection: importance of the malate-aspartate shuttle. Cardiovasc. Res. 2011, 91:382-391.
30. Papandreou I., Cairns R.A., Fontana L., Lim A.L., Denko N.C. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 2006, 3:187-197.
31. Pattappa G., Heywood H.K., De Bruijn J.D., Lee D.A. The metabolism of human mesenchymal stem cells during proliferation and differentiation. J. Cell. Physiol. 2010, 226(10):2562-2570.
32. Pattappa G., Thorpe S.D., Jegard N.C., Eng M., Heywood H., de Brujin J.D., Lee D. Continuous and uninterrupted oxygen tension influences the colony formation and oxidative metabolism of human mesenchymal stem cells. Tissue Eng. Part C 2013, 19(1):68-79.
33. Phinney D.G. Biochemical heterogeneity of mesenchymal stem cell populations: clues to their therapeutic efficacy. Cell Cycle 2007, 6:2884-2889.
34. R Development Core Team R: A Language and Environment for Statistical Computing 2008, R Foundation for Statistical Computing, Vienna, Austria.
35. Rattigan Y.I., Patel B.B., Ackerstaff E., Sukenick G., Koutcher J.A., Glod J.W., Banerjee D. Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment. Exp. Cell Res. 2012, 318:326-335.
36. Robey P.G. Cell sources for bone regeneration: the good, the bad, and the ugly (but promising). Tissue Eng. Part B Rev. 2011, 17:423-430.
37. Russell K.C., Lacey M.R., Gilliam J.K., Tucker H.A., Phinney D.G., O'Connor K.C. Clonal analysis of the proliferation potential of human bone marrow mesenchymal stem cells as a function of potency. Biotechnol. Bioeng. 2011, 108:2716-2726.
38. Szpalski C., Barbaro M., Sagebin F., Warren S.M. Bone tissue engineering: current strategies and techniques - Part II: cell types. Tissue Eng. Part B Rev. 2012, 18:258-269.
39. Ullah M.S., Davies A.J., Halestrap A.P. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1α-dependent mechanism. J. Biol. Chem. 2006, 281:9030-9037.
40. Utting J.C., Robins S.P., Brandao-Burch A., Orriss I.R., Behar J., Arnett T.R. Hypoxia inhibits the growth, differentiation and bone-forming capacity of rat osteoblasts. Exp. Cell Res. 2006, 312:1693-1702.
41. Van Winden W.A., Wittmann C., Heinzle E., Heijnen J.J. Correcting mass isotopomer distributions for naturally occurring isotopes. Biotechnol. Bioeng. 2002, 80:477-479.
42. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
43. Wittmann C., Hans M., Heinzle E. In vivo analysis of intracellular amino acid labelings by GC/MS. Anal. Biochem. 2002, 307:379-382.
44. Zahm A.M., Bucaro M.A., Srinivas V., Shapiro I.M., Adams C.S. Oxygen tension regulates preosteocyte maturation and mineralization. Bone 2008, 43:25-31.
45. Zhao F., Ma T. Perfusion bioreactor system for human mesenchymal stem cell tissue engineering: dynamic cell seeding and construct development. Biotechnol. Bioeng. 2005, 91:482-493.